» Articles » PMID: 21327836

Aspergillus Lung Disease in Patients with Sarcoidosis: a Case Series and Review of the Literature

Overview
Journal Lung
Specialty Pulmonary Medicine
Date 2011 Feb 18
PMID 21327836
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic cavitary pulmonary aspergillosis (CCPA) has been associated with advanced lung diseases. Pulmonary sarcoidosis, a granulomatous inflammatory disorder, is associated with CCPA. We identified CCPA in 2% of cases in a large cohort of sarcoidosis patients. We found a lack of response to medical treatment and poor outcome in this subgroup.

Citing Articles

A case of pulmonary co-infection with and Mucorales in a patient with sarcoidosis.

Sagawa T, Ohno S, Urata Y, Takemura T, Niki M, Kaneko Y Respir Med Case Rep. 2024; 52:102130.

PMID: 39524120 PMC: 11549992. DOI: 10.1016/j.rmcr.2024.102130.


Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?.

Baczek K, Piotrowski W Front Pharmacol. 2024; 15:1445923.

PMID: 39281278 PMC: 11392764. DOI: 10.3389/fphar.2024.1445923.


Distribution of species and risk factors for aspergillosis in mainland China: a systematic review.

Khan S, Bilal H, Shafiq M, Zhang D, Awais M, Chen C Ther Adv Infect Dis. 2024; 11:20499361241252537.

PMID: 38835831 PMC: 11149451. DOI: 10.1177/20499361241252537.


Prognosis of sarcoidosis and factors affecting prognosis.

Bilgin B, Bilgin M, Erol S, Celik G, Ozdemir Kumbasar O Sarcoidosis Vasc Diffuse Lung Dis. 2023; 40(4):e2023054.

PMID: 38126508 PMC: 10964996. DOI: 10.36141/svdld.v40i4.13244.


Sarcoidosis-associated pulmonary fibrosis: joining the dots.

Bandyopadhyay D, Mirsaeidi M Eur Respir Rev. 2023; 32(169).

PMID: 37758275 PMC: 10523156. DOI: 10.1183/16000617.0085-2023.


References
1.
Campbell J, WINTER J, Richardson M, Shankland G, Banham S . Treatment of pulmonary aspergilloma with itraconazole. Thorax. 1991; 46(11):839-41. PMC: 1021040. DOI: 10.1136/thx.46.11.839. View

2.
De Beule K, De Doncker P, Cauwenbergh G, Koster M, Legendre R, Blatchford N . The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987). Mycoses. 1988; 31(9):476-85. DOI: 10.1111/j.1439-0507.1988.tb03653.x. View

3.
Valeyre D, Soler P, Clerici C, PRE J, BATTESTI J, Georges R . Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax. 1988; 43(7):516-24. PMC: 461354. DOI: 10.1136/thx.43.7.516. View

4.
Marzouk K, Saleh S, Kannass M, Sharma O . Interferon-induced granulomatous lung disease. Curr Opin Pulm Med. 2004; 10(5):435-40. DOI: 10.1097/01.mcp.0000134400.88832.9c. View

5.
Guerra M, Santos N, Miranda J, Mota J, Leal F, Vouga L . [Surgical management of pulmonary aspergilloma]. Rev Port Cir Cardiotorac Vasc. 2009; 15(3):135-8. View